Figure 6. NOTCH accumulation in FBXW7-deficient BMSCs promotes CCL2 expression and cancer metastasis.
(A) Immunoblot analysis of FBXW7 substrates in the indicated BMSCs. (B) Relative abundance of Ccl2 mRNA in WT BMSCs infected with retroviruses encoding NICD1, c-MYC, or KLF5. (C) Luciferase assay for the Ccl2 gene in BMSCs infected with retroviruses for NICD1, c-MYC, or KLF5. (D) Relative abundance of Ccl2 mRNA in CAG-Cre-ERT2 Fbxw7Δ/Δ BMSCs incubated with DAPT. (E) WT and mutant forms of the mouse Ccl2 gene promoter fused to the firefly luciferase gene. Consensus binding sequences for NOTCH–RBP-Jκ are shown in bold. Proximal and distal amplicons in G are indicated. (F) Luciferase assay for the Ccl2 gene in CAG-Cre-ERT2 Fbxw7Δ/Δ BMSCs. (G) ChIP analysis of the Ccl2 gene promoter. Immunoprecipitation was performed with antibodies against NOTCH1 or with control IgG. (H and I) Intravenous transplantation with B16F10 cells for Fbxw7fl/fl (n = 8), Fbxw7fl/fl RbpJκfl/fl (n = 11), Mx1-Cre Fbxw7Δ/Δ (n = 5), and Mx1-Cre Fbxw7Δ/Δ RbpJκΔ/Δ (n = 8) mice. (J and K) Intravenous transplantation with B16F10 cells for Fbxw7fl/fl (n = 8), Fbxw7fl/fl c-Mycfl/fl (n = 7), Mx1-Cre Fbxw7Δ/Δ (n = 6), and Mx1-Cre Fbxw7Δ/Δ c-MycΔ/Δ (n = 8) mice. Gross appearance of the lungs (H and J) and their occupancy by B16F10 colonies (I and K) are shown. (L) Serum concentration of CCL2, determined by ELISA. Scale bars: 10 mm (H and J). Data are mean ± SD (n = 3) (B–D, F, G, and L); horizontal bars in I and K indicate means. **P < 0.01, ***P < 0.001, 1-way ANOVA and Bonferroni test (B–D, I, K, and L).